[Comparison of the effects of cytosine arabinoside, cytosine arabinoside and thioguanine, and cytosine arabinoside and daunorubicin in acute myeloid leukemia].
D000284:Administration, Oral; D000293:Adolescent; D000328:Adult; D000368:Aged; D002648:Child; D003561:Cytarabine / Q000008:administration & dosage / Q000627:therapeutic use*; D003630:Daunorubicin / Q000008:administration & dosage / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D006402:Hematologic Diseases / Q000209:etiology / Q000628:therapy; D006801:Humans; D007275:Injections, Intravenous; D015470:Leukemia, Myeloid, Acute / Q000188:drug therapy* / Q000401:mortality; D008875:Middle Aged; D012075:Remission, Spontaneous; D013866:Thioguanine / Q000008:administration & dosage / Q000627:therapeutic use*; D013997:Time Factors
D003561:Cytarabine; D013866:Thioguanine; D003630:Daunorubicin
Comparaison de l'effet de la cytosine arabinoside, de la cytosine arabinoside et de la thioguanine, de la cytosine arabinoside et de la daunorubicine dans les leucémies aiguës myéloïdes